Evidence for in vivo non-mutagenicity of the carcinogen hydrazine sulfate in target tissues of lacZ transgenic mice.
Transgenic mouse models permit the confirmation of in vitro mutagenicity in vivo without the constraints in the selection of tissues imposed by other in vivo assays. This feature is of particular importance in the determination of mutagenicity in the target tissues of carcinogens, especially those that are in vitro mutagens. Such information is critical in the determination of whether a chemical is carcinogenic via a genotoxic or non-genotoxic mechanism. Hydrazine sulfate is an in vitro mutagen that induces lung and liver tumours in mice. Transgenic mice from strain 40.6 (Mutamouse) were administered single oral doses up to a toxic concentration (400 mg/kg). No dose induced any lacZ mutations in lung, liver or bone marrow. Since the highest single dose used is higher than the cumulative dose that induced tumours in previous studies, it may be that either hydrazine sulfate is genotoxic in target tissues in vivo only when given in multiple doses or that it is a non-genotoxic carcinogen.
Douglas
G R
GR
Mutagenesis Section, Health Canada, Ottawa, Ontario.
Gingerich
J D
JD
Soper
L M
LM
D000284:Administration, Oral; D000818:Animals; D001853:Bone Marrow / Q000187:drug effects; D002273:Carcinogens / Q000633:toxicity; D006834:Hydrazines / Q000633:toxicity*; D066298:In Vitro Techniques; D007763:Lac Operon / Q000187:drug effects*; D008099:Liver / Q000187:drug effects; D008168:Lung / Q000187:drug effects; D051379:Mice; D008822:Mice, Transgenic; D009153:Mutagens / Q000633:toxicity*
D002273:Carcinogens; D006834:Hydrazines; D009153:Mutagens; C029424:hydrazine